Hesperidin: A Potential Therapeutic Agent against COVID-19.

COVID-19, aka Coronavirus Disease 2019, triggered by new severe acute respiratory syndrome coronavirus-2 or SARS-CoV-2, is now a public health emergency due to its rapid spread, high transmission efficiency, and severe viral pandemic that is significantly increasing the number of patients and associated deaths. Currently, no specific treatment is available for this highly contagious virus. The unavailability of effective and specific treatments and the severity of this epidemic situation potentiate medicinal chemists' in supporting new prophylactic or therapeutic interventions against COVID-19. This study discusses the therapeutic potential of hesperidin, a traditionally used herbal medicine with an exceptional safety profile. Recent studies on hesperidin advocate its promising potential in the prevention and management of COVID-19. This paper also discusses the recent clinical studies based on the previously documented antiviral activity of hesperidin. Herein, we propose the detailed preclinical and clinical manifestations of hesperidin based on its multifaceted bioactivities to develop a novel anti-COVID-19 lead.

Biofabricated BiOI with enhanced photocatalytic activity under visible light irradiation.

In the recent past, there has been a large-scale utilization of plant extracts for the synthesis of various photocatalysts. The biofabrication technology eliminates the usage of harmful chemicals and serves as an eco-friendly approach for environmental remediation. Herein, a comparative analysis between bismuth oxyiodide synthesized via Azadirachta indica (neem) leaf extract (BiOI-G) and without leaf extract (BiOI-C) has been envisaged. The BiOI-G and BiOI-C samples were characterized by spectral and microscopic techniques, which revealed that the Azadirachta indica assisted BiOI-G attained enhanced features over BiOI-C such as narrower band gap, large surface area, porosity, increased absorption range of visible light and effectual splitting of the photogenerated e--h+ pairs. Benefiting from these enhanced features, BiOI-G degraded methyl orange (MO), rhodamine B (RhB), and benzotriazole (BT) at a significantly higher rate in comparison to BiOI-C. The degradation rate of MO, RhB and BT by BiOI-G was observed to be 1.3, 1.25 and 1.29 times higher in comparison to BiOI-C. Moreover, BiOI-G displayed high stability upto five cycles of the photocatalytic activity, which endow its effectiveness as a highly-efficient green photocatalyst.